Bam Adebayo: Everything you need to know

Bam Adebayo

#13 C

Miami Heat

Status

OUT - Back Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

16.2

9.0

3.6

0.8

1.1

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	73	73	32.4	20.1	10.0	3.2	0.7	1.2	1.6	35	0	1.7	5.5	31.8%	5.2	10.2	50.9%	6.9	15.7	44.2%	4.5	5.8	77.8%	2.0	8.0	1.7	1.9	+331	55.1%
2024-25	78	78	34.3	18.1	9.6	4.3	0.7	1.3	2.1	38	1	1.0	2.8	35.7%	5.9	11.4	51.7%	6.9	14.3	48.5%	3.2	4.2	76.5%	2.4	7.2	2.1	2.1	+27	56.1%
2023-24	71	71	34.0	19.3	10.4	3.9	0.9	1.1	2.3	42	2	0.2	0.6	35.7%	7.3	13.7	52.8%	7.5	14.3	52.1%	4.1	5.5	75.5%	2.2	8.1	2.2	1.7	+50	57.6%
2022-23	75	75	34.6	20.4	9.2	3.2	0.8	1.2	2.5	31	0	0.0	0.2	8.3%	8.0	14.7	54.5%	8.0	14.9	54.0%	4.3	5.4	80.6%	2.5	6.7	2.8	1.3	+117	59.2%
2021-22	56	56	32.6	19.1	10.1	3.4	0.8	1.4	2.6	27	0	0.0	0.1	0.0%	7.3	12.9	56.2%	7.3	13.0	55.7%	4.6	6.1	75.3%	2.4	7.6	3.1	1.3	+300	60.8%
2020-21	64	64	33.5	18.7	9.0	5.4	1.0	1.2	2.6	33	2	0.0	0.1	25.0%	7.1	12.4	57.3%	7.1	12.5	57.0%	4.4	5.5	79.9%	2.2	6.7	2.3	2.0	+24	62.6%
2019-20	72	72	33.6	15.9	10.2	5.1	1.3	1.1	2.8	40	3	0.0	0.2	14.3%	6.1	10.8	56.4%	6.1	11.0	55.7%	3.7	5.3	69.1%	2.4	7.8	2.5	1.8	+244	59.8%
2018-19	82	28	23.3	8.9	7.3	2.2	0.8	0.9	1.5	11	0	0.0	0.2	20.0%	3.4	5.7	58.8%	3.4	5.9	57.6%	2.0	2.8	73.5%	2.0	5.3	2.5	1.5	+21	62.3%
2017-18	69	19	19.8	6.9	5.5	1.5	0.6	0.5	1.0	7	0	0.0	0.1	0.0%	2.5	4.8	52.3%	2.5	4.9	51.2%	1.9	2.6	72.1%	1.7	3.8	2.0	1.5	-34	57.0%
Career	640	536	30.8	16.2	9.0	3.6	0.8	1.1	2.1	264	8	0.4	1.1	31.6%	5.8	10.6	54.4%	6.1	11.8	52.2%	3.6	4.7	75.9%	2.2	6.8	2.3	1.7	+1080	58.6%

Career Averages

PTS

REB

AST

BLK

STL

16.4

9.2

3.5

0.6

0.9

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	4	4	38.3	17.5	11.0	4.3	0.3	1.0	3.0	2	0	1.8	5.3	33.3%	5.3	10.8	48.8%	7.0	16.0	43.8%	1.8	2.8	63.6%	4.0	7.0	2.3	1.4	-73	50.8%
2023-24	5	5	38.4	22.6	9.4	3.8	0.0	0.4	1.6	2	0	0.4	2.0	20.0%	9.2	17.4	52.9%	9.6	19.4	49.5%	3.0	4.2	71.4%	2.2	7.2	3.0	2.4	-36	53.2%
2022-23	23	23	37.0	17.9	9.9	3.7	0.7	0.8	2.7	11	1	0.0	0.1	0.0%	7.3	15.0	48.5%	7.3	15.1	48.1%	3.4	4.1	82.1%	2.7	7.1	3.1	1.4	+42	53.0%
2021-22	18	18	34.1	14.8	8.0	2.7	0.7	1.0	2.1	6	0	0.0	0.1	0.0%	5.8	9.7	59.8%	5.8	9.7	59.4%	3.2	4.2	76.3%	2.1	5.9	3.1	1.3	+78	63.8%
2020-21	4	4	34.0	15.5	9.3	4.3	0.5	1.3	2.8	1	0	0.0	0.0	0.0%	6.5	14.3	45.6%	6.5	14.3	45.6%	2.5	3.3	76.9%	3.5	5.8	2.8	1.5	-47	49.4%
2019-20	19	19	36.2	17.8	10.3	4.4	0.8	1.0	2.5	11	0	0.0	0.1	0.0%	6.5	11.5	56.6%	6.5	11.6	56.4%	4.7	6.1	78.3%	2.5	7.8	3.1	1.8	+61	62.5%
2017-18	5	0	15.4	3.4	4.0	0.0	0.4	0.0	0.4	0	0	0.0	0.2	0.0%	1.4	2.8	50.0%	1.4	3.0	46.7%	0.6	2.8	21.4%	1.8	2.2	1.6	0.0	-28	40.2%
Career	78	73	34.7	16.4	9.2	3.5	0.6	0.9	2.3	33	1	0.1	0.5	24.3%	6.3	12.0	52.8%	6.5	12.5	51.7%	3.3	4.4	75.7%	2.5	6.6	2.9	1.5	-3	56.7%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/13	ATL	L 119-118	19	13	9	3	0	0	0	3	0	0.0%	8	4	50.0%	11	4	36.4%	7	5	71.4%	2	7	0.0	+11	0	21	46.2%
10/8	SAS	L 112-107	21	9	4	0	0	1	3	3	1	33.3%	7	2	28.6%	10	3	30.0%	4	2	50.0%	0	4	0.0	-15	1	5	38.3%
10/6	MIL	L 103-93	16	5	7	2	1	0	5	0	0	0.0%	3	1	33.3%	3	1	33.3%	4	3	75.0%	0	7	0.4	+4	2	9	52.5%
10/4	ORL	L 126-118	12	7	5	1	0	0	0	0	0	0.0%	5	0	0.0%	5	0	0.0%	8	7	87.5%	2	3	0.0	-1	1	10	41.1%
Preseason Totals			17.5	8.5	6.3	1.5	0.3	0.3	2.0	1.5	0.3	16.7%	5.8	1.8	30.4%	7.3	2.0	27.6%	5.8	4.3	73.9%	1.0	5.3	0.8	-1	1.0	12.5	43.5%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	WAS	W 140-117	38	20	11	8	1	1	2	6	3	50.0%	8	4	50.0%	14	7	50.0%	3	3	100.0%	0	11	4.0	+22	0	36	65.3%
4/9	TOR	L 128-114	37	24	11	8	1	1	1	4	2	50.0%	10	7	70.0%	14	9	64.3%	5	4	80.0%	4	7	8.0	-10	4	39	74.1%
4/7	TOR	L 121-95	36	7	9	3	0	1	0	7	1	14.3%	6	1	16.7%	13	2	15.4%	2	2	100.0%	1	8	0.0	-13	0	11	25.2%
4/4	WAS	W 152-136	24	14	9	7	0	1	2	4	2	50.0%	2	1	50.0%	6	3	50.0%	7	6	85.7%	0	9	3.5	+25	1	28	77.1%
4/1	BOS	L 147-129	37	29	10	2	0	2	3	10	5	50.0%	11	5	45.5%	21	10	47.6%	8	4	50.0%	4	6	0.7	-23	2	28	59.1%
3/30	PHI	W 119-109	41	23	16	6	0	1	2	4	1	25.0%	7	4	57.1%	11	5	45.5%	13	12	92.3%	4	12	3.0	+27	2	42	68.8%
3/29	IND	L 135-118	32	15	12	3	1	0	1	3	0	0.0%	13	6	46.2%	16	6	37.5%	4	3	75.0%	0	12	3.0	-9	1	22	42.2%
3/27	CLE	L 149-128	30	14	16	3	1	1	2	8	1	12.5%	6	2	33.3%	14	3	21.4%	8	7	87.5%	1	15	1.5	-18	0	27	40.0%
3/25	CLE	W 120-103	33	17	10	7	0	2	1	9	1	11.1%	10	5	50.0%	19	6	31.6%	5	4	80.0%	1	9	7.0	-1	1	25	40.1%
3/23	SAS	L 136-111	28	18	3	4	0	1	0	10	2	20.0%	7	3	42.9%	17	5	29.4%	6	6	100.0%	0	3	0.0	-26	0	18	45.8%
3/21	HOU	L 123-122	45	32	21	4	0	2	1	4	2	50.0%	17	10	58.8%	21	12	57.1%	8	6	75.0%	5	16	4.0	+5	4	47	65.3%
3/19	LAL	L 134-126	37	28	10	2	0	1	0	8	3	37.5%	11	6	54.5%	19	9	47.4%	10	7	70.0%	2	8	0.0	-12	3	31	59.8%
3/14	ORL	L 121-117	38	20	7	1	2	4	2	7	2	28.6%	8	4	50.0%	15	6	40.0%	10	6	60.0%	1	6	0.5	-2	2	23	51.5%
3/12	MIL	W 112-105	34	21	8	2	0	1	2	5	0	0.0%	15	6	40.0%	20	6	30.0%	13	9	69.2%	4	4	1.0	+11	1	20	40.8%
3/10	WAS	W 150-129	41	83	9	3	2	2	5	22	7	31.8%	21	13	61.9%	43	20	46.5%	43	36	83.7%	1	8	0.6	+20	3	86	67.0%
3/8	DET	W 121-110	34	24	9	6	1	1	2	10	4	40.0%	7	3	42.9%	17	7	41.2%	6	6	100.0%	3	6	3.0	+13	1	35	61.1%
3/6	CHA	W 128-120	38	24	12	4	1	1	0	5	0	0.0%	21	10	47.6%	26	10	38.5%	5	4	80.0%	3	9	0.0	+9	2	24	42.6%
3/5	BKN	W 126-110	24	21	7	2	1	1	1	4	0	0.0%	11	7	63.6%	15	7	46.7%	8	7	87.5%	3	4	2.0	+10	5	22	56.7%
3/3	BKN	W 124-98	34	23	9	4	1	6	0	7	1	14.3%	17	10	58.8%	24	11	45.8%	0	0	0.0%	1	8	0.0	+22	3	28	47.9%
2/28	HOU	W 115-105	35	24	11	1	0	1	1	5	3	60.0%	12	6	50.0%	17	9	52.9%	6	3	50.0%	4	7	1.0	+16	3	26	61.1%
2/26	PHI	L 124-117	36	29	14	3	0	1	1	8	4	50.0%	12	6	50.0%	20	10	50.0%	8	5	62.5%	2	12	3.0	+2	2	37	61.6%
2/24	MIL	L 128-117	31	18	9	2	1	1	1	8	2	25.0%	11	6	54.5%	19	8	42.1%	0	0	0.0%	2	7	2.0	-3	3	16	47.4%
2/21	MEM	W 136-120	26	13	6	5	0	0	1	3	1	33.3%	4	3	75.0%	7	4	57.1%	5	4	80.0%	2	4	5.0	+27	0	22	70.7%
2/20	ATL	W 128-97	27	17	8	5	0	1	0	4	1	25.0%	10	7	70.0%	14	8	57.1%	2	0	0.0%	0	8	0.0	+29	0	25	57.1%
2/11	NOP	W 123-111	36	27	14	4	4	0	3	9	2	22.2%	10	4	40.0%	19	6	31.6%	17	13	76.5%	2	12	1.3	+15	1	38	51.0%
2/9	UTA	L 115-111	37	23	11	5	0	0	4	5	1	20.0%	13	7	53.8%	18	8	44.4%	10	6	60.0%	3	8	1.3	+0	4	24	51.3%
2/8	WAS	W 132-101	28	22	8	3	0	5	2	6	2	33.3%	9	7	77.8%	15	9	60.0%	2	2	100.0%	1	7	1.5	+41	1	30	69.3%
2/6	BOS	L 98-96	34	16	7	1	0	1	0	6	2	33.3%	7	3	42.9%	13	5	38.5%	6	4	66.7%	0	7	0.0	+8	2	16	51.2%
2/3	ATL	L 127-115	30	16	14	1	0	1	3	3	0	0.0%	13	4	30.8%	16	4	25.0%	8	8	100.0%	2	12	0.3	+0	3	22	41.0%
2/1	CHI	W 134-91	22	20	9	3	0	1	0	3	2	66.7%	8	6	75.0%	11	8	72.7%	4	2	50.0%	2	7	0.0	+26	0	33	78.4%
1/31	CHI	L 125-118	36	21	11	1	0	1	3	8	1	12.5%	10	6	60.0%	18	7	38.9%	9	6	66.7%	3	8	0.3	-8	1	20	47.8%
1/29	CHI	W 116-113	33	20	12	2	0	0	1	8	2	25.0%	11	5	45.5%	19	7	36.8%	4	4	100.0%	2	10	2.0	+6	0	26	48.2%
1/28	ORL	L 133-124	38	21	12	7	0	2	3	7	4	57.1%	7	3	42.9%	14	7	50.0%	4	3	75.0%	2	10	2.3	-4	0	32	66.6%
1/25	PHX	W 111-102	32	22	7	1	1	2	1	6	2	33.3%	10	4	40.0%	16	6	37.5%	8	8	100.0%	4	3	1.0	-7	4	22	56.4%
1/24	UTA	W 147-116	31	26	15	2	1	0	3	10	4	40.0%	9	4	44.4%	19	8	42.1%	6	6	100.0%	7	8	0.7	+19	1	34	60.1%
1/22	POR	L 127-110	37	32	10	2	1	3	3	7	1	14.3%	17	12	70.6%	24	13	54.2%	5	5	100.0%	3	7	0.7	-6	0	38	61.1%
1/20	SAC	W 130-117	30	25	7	5	1	1	1	5	4	80.0%	10	4	40.0%	15	8	53.3%	7	5	71.4%	0	7	5.0	+13	1	32	69.1%
1/19	GSW	L 135-112	25	4	12	3	0	0	1	5	0	0.0%	8	1	12.5%	13	1	7.7%	2	2	100.0%	5	7	3.0	-20	0	7	14.4%
1/17	OKC	W 122-120	32	30	12	4	0	1	1	10	6	60.0%	12	3	25.0%	22	9	40.9%	6	6	100.0%	6	6	4.0	+11	2	33	60.9%
1/15	BOS	L 119-114	33	22	4	5	0	0	1	7	3	42.9%	12	5	41.7%	19	8	42.1%	4	3	75.0%	3	1	5.0	+13	3	19	53.0%
1/13	PHX	W 127-121	31	29	9	4	1	2	1	6	4	66.7%	9	7	77.8%	15	11	73.3%	4	3	75.0%	3	6	4.0	+9	3	39	86.5%
1/11	OKC	L 124-112	31	6	14	4	1	1	2	1	0	0.0%	9	3	33.3%	10	3	30.0%	2	0	0.0%	1	13	2.0	-9	3	15	27.6%
1/10	IND	L 123-99	24	13	9	2	0	0	2	2	0	0.0%	10	5	50.0%	12	5	41.7%	3	3	100.0%	2	7	1.0	-23	1	18	48.8%
1/6	MIN	L 122-94	28	7	11	3	0	0	1	2	1	50.0%	9	2	22.2%	11	3	27.3%	0	0	0.0%	2	9	3.0	-6	0	12	31.8%
1/4	NOP	W 125-106	28	12	6	6	1	1	1	3	1	33.3%	11	4	36.4%	14	5	35.7%	1	1	100.0%	1	5	6.0	+23	1	16	41.6%
1/3	MIN	L 125-115	34	12	9	4	1	0	4	3	1	33.3%	10	4	40.0%	13	5	38.5%	2	1	50.0%	2	7	1.0	-9	2	15	43.2%
1/1	DET	W 118-112	32	15	14	0	1	2	1	2	1	50.0%	12	4	33.3%	14	5	35.7%	4	4	100.0%	3	11	0.0	+17	2	24	47.6%
12/29	DEN	W 147-123	21	13	10	4	0	1	2	2	1	50.0%	8	4	50.0%	10	5	50.0%	2	2	100.0%	3	7	2.0	+3	3	19	59.7%
12/23	TOR	L 112-91	34	9	12	3	0	2	1	2	0	0.0%	9	4	44.4%	11	4	36.4%	3	1	33.3%	1	11	3.0	-16	2	19	36.5%
12/21	NYK	L 132-125	33	14	9	0	0	0	3	3	0	0.0%	8	4	50.0%	11	4	36.4%	7	6	85.7%	3	6	0.0	-5	3	14	49.7%
12/19	BOS	L 129-116	36	16	10	4	0	1	3	1	0	0.0%	12	6	50.0%	13	6	46.2%	6	4	66.7%	4	6	1.3	-15	5	16	51.2%
12/18	BKN	W 106-95	31	8	17	1	3	1	3	2	0	0.0%	11	4	36.4%	13	4	30.8%	2	0	0.0%	2	15	0.3	+12	5	12	28.8%
12/15	TOR	L 106-96	33	20	10	2	0	1	2	3	1	33.3%	10	6	60.0%	13	7	53.8%	8	5	62.5%	0	10	1.0	-5	2	24	60.5%
12/9	ORL	L 117-108	35	19	8	2	3	1	0	3	0	0.0%	11	7	63.6%	14	7	50.0%	6	5	83.3%	1	7	0.0	+6	1	28	57.1%
12/6	SAC	L 127-111	24	9	7	3	0	0	0	3	0	0.0%	6	4	66.7%	9	4	44.4%	2	1	50.0%	2	5	0.0	-17	0	14	45.5%
12/5	ORL	L 106-105	39	24	15	3	2	2	5	4	2	50.0%	11	7	63.6%	15	9	60.0%	6	4	66.7%	2	13	0.6	+3	2	38	68.0%
12/3	DAL	L 118-108	28	21	7	1	0	1	1	6	1	16.7%	13	9	69.2%	19	10	52.6%	0	0	0.0%	1	6	1.0	-6	1	21	55.3%
12/1	LAC	W 140-123	31	27	14	3	2	2	1	8	5	62.5%	9	5	55.6%	17	10	58.8%	2	2	100.0%	3	11	3.0	+33	0	41	75.5%
11/29	DET	L 138-135	33	15	10	1	1	2	3	2	1	50.0%	7	4	57.1%	9	5	55.6%	6	4	66.7%	2	8	0.3	+14	1	23	64.4%
11/26	MIL	W 106-103	28	17	11	2	1	0	1	5	1	20.0%	11	6	54.5%	16	7	43.8%	2	2	100.0%	0	11	2.0	-11	0	22	50.4%
11/24	DAL	W 106-102	29	17	6	1	2	1	2	3	0	0.0%	10	5	50.0%	13	5	38.5%	11	7	63.6%	3	3	0.5	-16	1	18	47.6%
11/23	PHI	W 127-117	32	18	13	1	0	1	2	4	1	25.0%	10	6	60.0%	14	7	50.0%	4	3	75.0%	3	10	0.5	+4	1	24	57.1%
11/21	CHI	W 143-107	29	18	7	5	3	0	1	5	2	40.0%	6	2	33.3%	11	4	36.4%	10	8	80.0%	1	6	5.0	+24	3	26	58.4%
11/19	GSW	W 110-96	28	20	7	3	2	1	1	4	3	75.0%	9	4	44.4%	13	7	53.8%	3	3	100.0%	1	6	3.0	+15	1	27	69.8%
11/5	DEN	L 122-112	8	2	1	0	0	0	0	2	0	0.0%	3	1	33.3%	5	1	20.0%	0	0	0.0%	0	1	0.0	+4	1	2	20.0%
11/3	LAC	W 120-119	30	25	10	4	0	2	2	4	2	50.0%	14	8	57.1%	18	10	55.6%	5	3	60.0%	0	10	2.0	+2	1	33	61.9%
11/2	LAL	L 130-120	36	17	8	5	1	3	0	5	1	20.0%	6	5	83.3%	11	6	54.5%	4	4	100.0%	1	7	0.0	-13	1	33	66.6%
10/30	SAS	L 107-101	37	31	10	3	1	1	2	13	4	30.8%	14	8	57.1%	27	12	44.4%	4	3	75.0%	1	9	1.5	+7	2	31	53.9%
10/28	CHA	W 144-117	30	26	6	2	0	0	1	5	3	60.0%	11	7	63.6%	16	10	62.5%	4	3	75.0%	1	5	2.0	+29	2	26	73.2%
10/26	NYK	W 115-107	38	19	13	3	0	1	6	5	1	20.0%	10	4	40.0%	15	5	33.3%	8	8	100.0%	1	12	0.5	+10	1	25	51.3%
10/24	MEM	W 146-114	28	24	5	4	0	1	1	8	4	50.0%	11	4	36.4%	19	8	42.1%	4	4	100.0%	1	4	4.0	+25	2	22	57.8%
10/22	ORL	L 125-121	34	15	12	2	0	0	4	5	1	20.0%	8	3	37.5%	13	4	30.8%	7	6	85.7%	3	9	0.5	-2	3	17	46.6%
Regular Season Totals			32.4	20.0	10.0	3.2	0.7	1.2	1.7	5.5	1.8	31.8%	10.2	5.1	50.5%	15.7	6.9	43.9%	5.8	4.5	78.0%	2.0	8.0	1.9	+315	1.7	28.0	55.0%

Bam Adebayo: Breaking News

Adebayo (back) won't return to Tuesday's Play-In Tournament game against the Hornets. He'll finish with six points (3-3 FG), three rebounds, one assist and one steal across 11 minutes. This is a huge loss for the Heat, as Adebayo is one of Miami's go-to options on offense while also operating as the anchor on the defensive end. Without Adebayo, look for Kel'el Ware to continue handling a bigger role in the frontcourt for Miami.

Adebayo is questionable to return to Tuesday's Play-In Tournament game against the Hornets due to a lower-back injury. Adebayo took a hard fall early in the second quarter and is in jeopardy of missing the remainder of the contest. Kel'el Ware should help pick up the slack while Adebayo is on the sideline.

Adebayo exited to the locker room in the second quarter of Tuesday's Play-In Tournament game against the Hornets due to an apparent back injury, Anthony Chiang of the Miami Herald reports. Adebayo took a hard fall on his backside and walked gingerly to the locker room early in the second quarter. The star big man can be considered questionable to return until more information comes to light.